MedTrace Logo

FDG-PET in the Diagnosis of Autoimmune Encephalitis

NCT06019975 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2026-03-24

No results posted yet for this study

Summary

The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is:

•is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.

Conditions

  • Autoimmune Encephalitis

Interventions

DIAGNOSTIC_TEST

FDG-PET

Brain FDG-PET

Sponsors & Collaborators

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Simone Beretta, MD, PhD · University of Milano Bicocca

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2027-03-31
Completion
2027-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06019975 on ClinicalTrials.gov